Patient information sheets

Fair PharmaCare Plan

Information sheets are available in English, عربى (Arabic), Français, 简体中文 (Simplified Chinese),  繁體中文 (Traditional Chinese), ਪੰਜਾਬੀ (Punjabi), فارسی (Farsi), 한국어 (Korean), Español, Tiếng Việt (Vietnamese) and Filipino (Tagalog). Open the accordions below to find the ones you or your patients need.

Medical devices and supplies

BC Smoking Cessation Program

Biosimilars

The following drugs are involved in PharmaCare biosimilar switching:

• Adalimumab (PDF)—drug used for rheumatological indications 
• Etanercept (PDF)—specifically for plaque psoriasis
• Etanercept (PDF)—drug used for rheumatological indications 
• Infliximab (PDF)—drug used for rheumatological and dermatological indications
• Insulin Aspart and Insulin Lispro (PDF)—drug used for diabetes (type 1 and 2) 
• Insulin Glargine (PDF)—drug used for diabetes (type 1 and 2) 
• Rituxumab (PDF)—drug used for vascular and rheumatological indications 

Drug information

• Cholinesterase Inhibitors (PDF)—memory loss medications used in the treatment of Alzheimer's disease
• Oral Anticoagulants in Atrial Fibrillation (AF) (PDF)—drugs used to thin blood to prevent blood clots from forming in patients with AF which causes heart rhythm disorders

Other PharmaCare plans and policies

• Special Authority Coverage (PDF)
• BC Palliative Care Benefits Program (PDF)
• PharmaCare Policy on Pharmacy Inducements (PDF)
• The Drug Review Process in B.C. (PDF)
• Reference Drug Program poster (PDF)

Health education

• Preventing Stroke When You Have Atrial Fibrillation: A Guide (PDF)